DrugPatentWatch Database Preview

Switzerland Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	0966454	C00966454/01	Switzerland	PRODUCT NAME: DABIGATRANETEXILAT; REGISTRATION NO/DATE: SWISSMEDIC 61385 29.05.2012
European Patent Office	0716600	C00716600/01	Switzerland	PRODUCT NAME: NEPAFENAC; REGISTRATION NUMBER/DATE: SWISSMEDIC 58745 24.09.2008
European Patent Office	1175904	C01175904/01	Switzerland	FORMER OWNER: SCHERING CORPORATION, US
European Patent Office	1305329	C01305329/01	Switzerland	PRODUCT NAME: FLUTICASON FUROAT; REGISTRATION NUMBER/DATE: SWISSMEDIC 57968 19.12.2007
European Patent Office	1405852	C01405852/01	Switzerland	PRODUCT NAME: EDOXABAN; REGISTRATION NO/DATE: SWISSMEDIC 65149 31.03.2015
European Patent Office	1189916	C01189916/01	Switzerland	PRODUCT NAME: REGADENOSON; REGISTRATION NO/DATE: SWISSMEDIC 66137 28.07.2017
European Patent Office	0770388	C00770388/01	Switzerland	FORMER REPRESENTATIVE: BOHEST AG, CH